Globe Star Therapeutics Corp GSTC
We take great care to ensure that the data presented and summarized in this overview for GlobeStar Therapeutics Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in GSTC
Top Purchases
Top Sells
About GSTC
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is based in Richland, Washington.
Insider Transactions at GSTC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 03
2023
|
James C Katzaroff CEO |
BUY
Other acquisition or disposition
|
Direct |
70,422,535
+46.69%
|
$0
$0.01 P/Share
|